An overview of glycopyrrolate/eFlow® CS in COPD-Reference-Cited by-同舟云学术

An overview of glycopyrrolate/eFlow® CS in COPD

Published:2018-05-28 Issue:6 Volume:12 Page:447-459
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Kerwin Edward¹,Ferguson Gary T.²

Affiliation:

1. Clinical Research Institute of Southern Oregon, Inc., Medford, OR, USA

2. Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA

Funder

Sunovion

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2018.1476853

Reference69 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2018 [cited 2018 Mar 05]. Available from: http://goldcopd.org/.

2. Chronic obstructive pulmonary disease

3. Pathology, pathogenesis, and pathophysiology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Generation Nebulizers;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2024-06-01

2. Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review;Respiratory Medicine;2021-11

3. Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate;International Journal of Chronic Obstructive Pulmonary Disease;2021-04

4. In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®;Pulmonary Therapy;2020-08-18

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies

;International Journal of Chronic Obstructive Pulmonary Disease;2020-04